Skip to main content

Mechanisms ofall-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells

Abstract

Retinoic acids (RA) play a key role in myeloid differentiation through their agonistic nuclear receptors (RARα/RXR) to modulate the expression of target genes. In acute promyelocytic leukemia (APL) cells with rearrangement of retinoic acid receptor α (RARα) (including: PML-RARα, PLZF-RARα, NPM-RARα, NuMA-RARα or STAT5b-RARα) as a result of chromosomal translocations, the RA signal pathway is disrupted and myeloid differentiation is arrested at the promyelocytic stage. Pharmacologic dosage ofall-trans retinoic acid (ATRA) directly modulates PML-RARα and its interaction with the nuclear receptor co-repressor complex, which restores the wild-type RARα/RXR regulatory pathway and induces the transcriptional expression of downstream genes. Analysing gene expression profiles in APL cells before and after ATRA treatment represents a useful approach to identify genes whose functions are involved in this new cancer treatment. A chronologically well coordinated modulation of ATRA-regulated genes has thus been revealed which seems to constitute a balanced functional network underlying decreased cellular proliferation, initiation and progression of maturation, and maintenance of cell survival before terminal differentiation.

This is a preview of subscription content, access via your institution.

Abbreviations

Mel:

Murine erythroid leukemia

DMSO:

dimethylsulfoxide

HMBA:

hexamethylenebiacetamide

TPA:

phorbol ester 12-O-tetradecanoylphorbol-13-acetate

RA:

retinoic acid

ATRA:

all-trans RA

APL:

acute promyelocytic leukemia

CR:

complete remission

RARα:

RA receptor α

RXRs:

retinoid X receptors

VDRs:

vitamin D receptors

THRs:

thyroid hormone receptors

CoR:

co-repressor

CoA:

co-activator

RARE:

RA response element

N-CoR:

nuclear receptor CoR

SMRT:

silencing mediator of retinoid and thyroid receptor

HDAC:

histone deacetylase

CBP:

CREB binding protein

P300:

protein p300

P/CAF:

P300/CBP associated factor

P/CIP:

P300/CBP interaction protein

ACTR:

activator of thyroid hormone and retinoid

NcoA-1:

nuclear receptors coactivator-1

SRC-1:

steroid hormone receptor coactivator-1

HAT:

histone acetylase

NLS:

nuclear localization signal

PODs:

PML oncogenic domains

PLZF:

promyelocytic leukemia zinc finger

ZID:

zinc finger protein with interaction domain

POZ:

pox-virus and zinc finger

BTB:

broad complex, tramtrack, bric a brac

NPM:

nucleophosmin

NuMA:

nuclear mitotic apparatus

TSA:

tricostratin A

DD-PCR:

differential display-PCR

SSH:

suppression subtractive hybridization

References

  • Allen J D and Adams J M 1993 Enforced expression of Hlx homeobox gene prompts myeloid cell maturation and altered adherence properties of T cells;Blood 81 3242–3251

    PubMed  CAS  Google Scholar 

  • Arnould C, Philippe C, Bourdon V, Gregoire M J, Berger R and Jonveaux P 1999 The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor [alpha] in acute promyelocytic leukemia;Human Mol. Genet. 8 1741–1749

    Article  CAS  Google Scholar 

  • Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Sakamaki H, Tsubaki K, Saito K and Ohno R 1997 All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG);Cancer-Chemother-Pharmacol. (Suppl.) 40 S30–35

    Article  CAS  Google Scholar 

  • Breitman T, Collins S J and Keene B 1981 Terminal differentiation of human promeylocytic cells in culture in response to retinoic acid;Blood 57 1000–1004

    PubMed  CAS  Google Scholar 

  • Breitman T R, Selonick S E and Collins S S 1980 Induction of differentiation of human promyelocytic leukemia cell line (HL-60) by retinoic acid;Proc. Natl. Acad. Sci. USA 77 2936–2940

    PubMed  Article  CAS  Google Scholar 

  • Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci P G, Atwater S and Bishop J M 1997 A PML-RARa transgene initiates murine acute promyelocytic leukemia;Proc. Natl. Acad. Sci. USA 94 2551–2556

    PubMed  Article  CAS  Google Scholar 

  • Burnett A K, Grimwade D, Solomon E, Wheatley K and Goldstone A H 1999 Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the randomized MRC trial;Blood 93 4131–4143

    PubMed  CAS  Google Scholar 

  • Carapeti M, Aguiar R C T, Goldman J M and Cross N C 1998 A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia;Blood 91 3127–3133

    PubMed  CAS  Google Scholar 

  • Chambon P 1996 A decade of molecular biology of retinoic acid receptors;FASEB J. 10 940–954

    Google Scholar 

  • Chen S J, Chen Z, Chen A, Tong J H, Dong S, Wang Z Y, Waxman S and Zelent A 1992 Occurrence of distinct PML-RARa fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction;Oncogene 7 1223–1232

    PubMed  CAS  Google Scholar 

  • Chen Z, Brand N J, Chen A, Chen S J, Tong J H, Wang Z Y, Waxman S and Zelent A 1993 Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-a locus due to a variant t(11; 17) translocation associated with acute promyelocytic leukemia;EMBO J. 12 1161–1167

    PubMed  CAS  Google Scholar 

  • Chen Z, Tong J H, Dong S, Zhu J, Wang Z Y and Chen S J 1996 Retinoic acid regulatory pathways, chromosomal translocations and acute promyelocytic leukemia;Genes Chromosomes Cancer 15 147–156

    Google Scholar 

  • Cheng G X, Zhu X H, Men X Q, Wang L, Huang Q H, Jin X L, Xiong S M, Zhu J, Guo W M, Chen J Q, Xu S F, So E, Chan L C, Waxman S, Zelent A, Chen G Q, Dong S, Liu J X and Chen S J 1999 Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARa and NPM-RARa;Proc. Natl. Acad. Sci. USA 96 6218–6223

    Google Scholar 

  • Chomienne C, Balitrand N, Ballerini P, Castaigne S, de The H and Degos L 1991 All-trans retinoic acid modulates the retinoic acid receptor alpha in promyelocytic cells;J. Clin. Invest. 88 2150–2154

    PubMed  CAS  Article  Google Scholar 

  • Collins S J, Robertson K A and Mueller L 1990 Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha);Mol. Cell Biol. 10 2154–2163

    PubMed  CAS  Google Scholar 

  • Damm K, Heyman R A, Umesono K and Evans R M 1993 Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants;Proc. Natl. Acad. Sci. USA 90 2989–2993

    PubMed  Article  CAS  Google Scholar 

  • de Thé H, Lavau C, Marchio A, Chomienne C, Degos L and Dejean A 1991 The PML-RARa fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR;Cell 66 675–684

    PubMed  Article  Google Scholar 

  • Dhordain P, Albagli O, Lin R J, Ansieau S, Quief S, Leutz A, Kerckaert J P, Evans R M and Leprince D 1997 Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/ BCL6 oncoprotein;Proc. Natl. Acad. Sci. USA 94 10762–10767

    PubMed  Article  CAS  Google Scholar 

  • Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong H J, Wang Z Y, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A and Chen S J 1996 Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of promyelocytic leukemia zinc finger-retinoic acid receptor a fusion protein;Proc. Natl. Acad. Sci. USA 93 3624–3629

    Article  Google Scholar 

  • Duprez E, Tong J H, Derre J, Chen S J, Berger R, Chen Z and Lanotte M 1997 JEM-1, a novel gene encoding a leucine-zipper nuclear factor upregulated during retinoid-induced maturation of NB4 promyelocytic leukemia;Oncogene 14 1563–1570

    PubMed  Article  CAS  Google Scholar 

  • Dyck J A, Maul G G, Miller W H Jr, Chen J D, Kakizuka A and Evans R M 1994 A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein;Cell 76 333–343

    PubMed  Article  CAS  Google Scholar 

  • Fenaux P, Chastag C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto J J, Gardin C, Makhoul P C, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel J S, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C and Degos L 1999 A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia;Blood 94 1192–1200

    PubMed  CAS  Google Scholar 

  • Freedman L P 1999 Increasing the complexity of coactivation in nuclear receptor signaling;Cell 97 5–8

    PubMed  Article  CAS  Google Scholar 

  • Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi P P, Donti E, Biondi A, Lo Coco F, Grignani F and Pelicci P G 1994 Acute promyelocytic leukemia: from genetics to treatment;Blood 83 10–25

    PubMed  CAS  Google Scholar 

  • Grignani F, Matteis S D, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara F F, Zamir I, Seiser C, Grignani F, Lazar M A, Minucci S and Pelicci P G 1998 Fusion proteins of the retinoic acid receptor-a recruit histone deacetylase in promyelocytic leukemia;Nature (London) 391 815–818

    Google Scholar 

  • Gudas L J 1994 Retinoids and vertebrate development;J. Biol. Chem. 269 15399–15402

    PubMed  CAS  Google Scholar 

  • Guidez F, Petrie K, Lu H, Ford A M, Hannemann J, MacGregor A, Benett C, Ito Y, Ghysdael J, Greaves M, Wiedemann L M and Zelent A 1999 Childhood leukaemia associated TEL-AML1 oncoprotein binds nuclear receptor co-repressor N-CoR and functions as a histone deacetylase dependent transcriptional repressor;Blood (Suppl. 1)94 693a

    Google Scholar 

  • Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman S and Zelent A 1998 Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARα underlie molecular pathogenesis and treatment of acute promyelocytic leukemia;Blood 91 2634–2642

    PubMed  CAS  Google Scholar 

  • He L Z, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A and Pandolfi P P 1998 Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL;Nat. Genet. 18 126–135

    PubMed  Article  CAS  Google Scholar 

  • Huang M E, YeY C, Chen S R, Chai J R, Lu J X, Zhoa L, Gu L J and Wang Z Y 1988 Use of all-trans retinoic acid in treatment of acute promyelocytic leukemia;Blood 72 567–572

    PubMed  CAS  Google Scholar 

  • Huang M E, Ye Y C and Zhao L 1987 Treatment of acute pro-myelocytic leukemia by retinoic acid with or without low dose cytosine arabinoside: report of 4 cases;Chung Hua Nei Ko Tsa Chih 26 330–332

    PubMed  CAS  Google Scholar 

  • Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M, Ohki M and Hayashi Y 1997 Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11; 22) (q23; q13);Blood 90 4699–4704

    PubMed  CAS  Google Scholar 

  • Janson J H, de Ridder M C, Geertsma W M, Erpelinck C A, van Lom K, Smit E M, Slater R, vd Reijden B A, de Greef G E, Sonneveld P and Lowenberg B 1999 Complete remission of t(11; 17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor;Blood 94 39–45

    Google Scholar 

  • Kakizuka A, Miller W H Jr, Umesono K, Warrell R P Jr, Frankel S R, Murty V V, Dmitrovsky E and Evans R M 1991 Chromosome translocation t(15; 17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML;Cell 66 663–674

    PubMed  Article  CAS  Google Scholar 

  • Kenneth W and Harris P 1997 Cell cycle exit upon myogenic differentiation;Curr. Opin. Genet. Dev. 7 597–602

    Article  Google Scholar 

  • Kogan S C, Hong S-H, Shultz D B, Privalsky M L and Bishop J M 2000 Leukemia initiated by PML/RARa: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable;Blood 95 1541–1550

    PubMed  CAS  Google Scholar 

  • Koken M H M, Puvion-Dutilleul F, Guillemin M C, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F and Chomienne C 1994 The t(15; 17) translocation alters a nuclear body in a retinoic acid-reversible fashion;EMBO J. 13 1073–1083

    PubMed  CAS  Google Scholar 

  • Kosugi H, Towatari M, Hatano S, Kitamura K, Kiyoi H, Kinoshita T, Tanimoto M, Murate T, Kawashima K, Saito H and Naoe T 1999 Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy;Leukemia 13 1316–1324

    PubMed  Article  CAS  Google Scholar 

  • Leroy P, Naksharti H and Chambon P 1991 Mouse retinoic acid receptor a2 isoform is transcribed from a promoter that contains a retinoic acid response element;Proc. Natl. Acad. Sci. USA 88 10138–10142

    PubMed  Article  CAS  Google Scholar 

  • Lin R J, Nagy L, Inoue S, Shao W, Miller W H Jr and Evans R M 1998 Role of the histone deacetylase complex in acute promyelocytic leukemia;Nature (London) 391 811–814

    Article  CAS  Google Scholar 

  • Liu M, Iavarone A and Freedman L P 1996 Transcriptional activation of the human P21WAF1/CIP1 gene by retinoic acid receptor. Correlation with retionid induction of U937 cell differentiation;J. Biol. Chem. 271 31723–31728

    Google Scholar 

  • Liu T X, Zhang J W, Tao J, Zhang R B, Zhang Q H, Zhao C J, Tong J H, Lanotte M, Waxman S, Chen S J, Mao M, Hu G X, Zhu L and Chen Z 2000 Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells;Blood 96 1496–1504

    PubMed  CAS  Google Scholar 

  • Liu T X, Zhang J W, Zhang R B, Wu J S, Tao J, Tong J H, Yu M, Sun Y W, Lanotte M, Waxman S, Zhu L, Chen S J, Chen Z and Mao M 1998 Identification of the molecular pathways underlying the retinoic acid-induced differentiation of acute promyelocytic leukemia cells;Blood 92 193a

    Google Scholar 

  • Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, Gansmuller A and Chambon P 1994 Function of the retinoic acid receptors (RARs) during development. (I) Craniofacial and skeletal abnormalities in RAR double mutants;Development 120 2723–2748

    PubMed  CAS  Google Scholar 

  • Magli M C, Barba P, Celetti A, De Vita G, Cillo C and Boncinelli E 1991 Coordinate regulation of HOX genes in human hematopoietic cells;Proc. Natl. Acad. Sci. USA 88 6348–6352

    PubMed  Article  CAS  Google Scholar 

  • Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti M C, Rodeghiero F, Saglio G, Vegna M L, Visani G, Jehn U, Willemze R, Muus P, Pelicci P G, Biondi A and Lo Coco F 1997 Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic and idarubicin (AIDA) therapy. Gruppo Italiono-Malattie Emutologiche Maligne dell'Adulto and Associazine Italian di Ematologia ed Oncologia Pediatrica Cooperative Groups;Blood 90 1014–1021

    PubMed  CAS  Google Scholar 

  • Mao M, Yu M, Tong J H, Ye J, Zhu J, Huang Q H, Fu G, Yu L, Zhao S Y, Waxman S, Lanotte M, Wang Z Y, Tan J Z, Chan S J and Chen Z 1996 RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia;Proc. Natl. Acad. Sci. USA 93 5910–5914

    Article  Google Scholar 

  • Melnick A and Licht J D 1999 Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia;Blood 93 3167–3215

    PubMed  CAS  Google Scholar 

  • Mendelson C, Lohnes D, Decimo D, Lufkin T, LeMeur M, Chambon P and Mark M 1994 Function of the retinoic acid receptors (RARs) during development. (II) Multiple abnormalities at various stages of organogenesis in RAR double mutants;Development 120 2749–2771

    Google Scholar 

  • Morosetti R, Park D J, Chumakov A M, Grillier I, Shiohara M, Gombart A F, Nakamaki T, Weinberg K and Koeffler H P 1997 A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation;Blood 90 2591–2600

    PubMed  CAS  Google Scholar 

  • Müller S, Matunis M J and Dejean A 1998 Conjugating with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus;EMBO J. 17 61–70

    PubMed  Article  Google Scholar 

  • Nakamura T, Largaespada D A, Shaughnessy J D Jr, Jenkins N A and Copeland N G 1996 Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias;Nat. Genet. 12 149–153

    Article  Google Scholar 

  • Nervi C, Ferrara F F, Fanelli M, Rippo M R, Tomassini B, Ferrucci P F, Ruthardt M, Gelmetti V, Gambacorti-Passerini C, Diverio D, Grignani F, Pelicci P G and Testi R 1998 Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RAR alpha fusion protein;Blood 92 2244–2251

    PubMed  CAS  Google Scholar 

  • Ogura T and Evans R M.1995 A retinoic acid-triggered cascade of HOXB1 gene activation;Proc. Natl. Acad. Sci. USA 92 387–391

    PubMed  Article  CAS  Google Scholar 

  • Park D J, Chumakov A M, Grillier I, Vuong P T, Silla A G, Chih D Y, Morosetti R, Gombart A F and Koeffler H P 1997 C/EBPε: The putative target for retinoids in the treatment of acute promyelocytic leukemai;Blood 90 576a (abstr, supp. 1)

    Google Scholar 

  • Perez A, Kastner P, Sethi S, Lutz Y, Reibel C and Chambon P 1993 PML-RAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR;EMBO J. 12 3171–3182

    PubMed  CAS  Google Scholar 

  • Perlmann T and Evans R M 1997 Nuclear receptors in Sicily: all in the famiglia;Cell 90 391–397

    PubMed  Article  CAS  Google Scholar 

  • Quenech'Du N, Ruchaud S, Khelef N, Guiso N and Lanotte M 1998 A sustained increase in the endogenous level of cAMP reduced the retinoid concentration required for APL cell maturation to near physiological levels;Leukemia 12 1829–1833

    PubMed  Article  Google Scholar 

  • Raelson J V, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci P G and Miller W H Jr 1996 The PML/RARα concoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells;Blood 88 2826–2832

    Google Scholar 

  • Redner R L, Ruch E A, Faas S, Rudert W A and Corey S J 1996 The t(5; 17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion;Blood 87 882–886

    Google Scholar 

  • Robertson K A, Emami B and Collins S J 1992 Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity;Blood 80 1885–1889

    PubMed  CAS  Google Scholar 

  • Robertson K A, Emami B, Mueller L, and Collins S J 1992 Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells;Mol. Cell Biol. 12 3743–3749

    PubMed  CAS  Google Scholar 

  • Rowle J D, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider N R, Barredo J C, Cantu E S, Schlegelberger B, Behm F, Doggett N A, Borrow J and Zeleznik-Le N 1997 All patients with the t(11; 16) (q23; p13.3) that involves MLL and CBP have treatment-related hematologic disorders;Blood 90 535–541

    Google Scholar 

  • Sainty D, Liso V, Cantu-Rajnoldi A, Head D, Mozziconacci M J, Benattar L, Arnoulet C, Grimwade D, Biondi A, Birg F, Lafage-Pochitaloff M, Hagemeijer A and Flandrin G 1998 Morphological presentation of acute promyelocytic leukemia (APL) lacking the classical t(15; 17) with special reference to a series of 9 cases with t(11; 17);Blood (Suppl. 1) 92 603a

    Google Scholar 

  • Smith M A, Parkinson D R, Cheson B D and Friedman M A 1992 Retinoids in cancer therapy;J. Clin. Oncol. 10 839–864

    PubMed  CAS  Google Scholar 

  • So C W, Dong S, So C K, Cheng G X, Huang Q H, Chen S J and Chan L C 2000 The impact of differential binding of wild-type RARα, PML-, PLZF- and NPM-RARα fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia;Leukemia 14 77–83

    PubMed  Article  CAS  Google Scholar 

  • Steinman R A, Huang J P, Yaroslavskiy B, Goff J P, Ball E D and Nguyen A 1998 Regulation of P21(WAF1) expression during normal myeloid differentiation;Blood 91 4531–4542

    PubMed  CAS  Google Scholar 

  • Sun G L, Tan X M and Cai J R 1986 Studies on diverse inducers of differentiation on leukemic cells;Chin. J. Hematol. 7 479–482

    Google Scholar 

  • Tallman M S, Andersen J W, Schiffer C A, Appelbaum F R, Feusner J H, Ogden A, Shepherd L, Willman C, Bloomfield C D, Rowe J M and Wiernik P H 1997 All-trans retinoic acid in acute promyelocytic leukemia;N. Engl. J. Med. 337 1021–1028

    PubMed  Article  CAS  Google Scholar 

  • Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander E S and Golub T R 1999 Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation;Proc. Natl. Acad. Sci. USA 96 2907–2912

    PubMed  Article  CAS  Google Scholar 

  • Tsai S and Collins S J 1993 A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage;Proc. Natl. Acad. Sci. USA 90 7153–7157

    PubMed  Article  CAS  Google Scholar 

  • Wang J, Hoshino T, Redner R L, Kajigaya S and Liu J M 1998 ETO fusion partner in t(8; 21) acute myeloid leukemia represses transcription by interaction with human N-coR/ mSin3/HDAC1 complex;Proc. Natl. Acad. Sci. USA 95 10860–10865

    PubMed  Article  CAS  Google Scholar 

  • Wang J, Saunthararajah Y, Redner R L and Liu J M 1999 Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells;Cancer Res. 59 2766–2769

    PubMed  CAS  Google Scholar 

  • Wang Z G, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F and Pandolfi P P 1998a Role of PML in cell growth and the retinoic acid pathway;Science 279 1547–1551

    PubMed  Article  CAS  Google Scholar 

  • Wang Z G, Ruggero D, Ronchetti S, Zhong S, Gaboli M, Rivi R and Pandolfi P P 1998b PML is essential for multiple apoptotic pathways;Nat. Genet. 20 266–272

    PubMed  Article  CAS  Google Scholar 

  • Wang Z Y, Sun G L and Ye Y C 1990 Treatment of acute promyelocytic leukemia with all-trans retinoic acid. Results of 90 cases;Chin. J. Hematol. 11 480–486

    Google Scholar 

  • Warrell R P Jr, de The H, Wang Z Y and Degos L 1993 Acute promyelocytic leukemia;N. Engl. J. Med. 329 177–189

    PubMed  Article  CAS  Google Scholar 

  • Warrell R P Jr, Frankel S R, Miller W H Jr, Scheinberg D A, Itri L M, Hittelman W N, Vyas R, Andreeff M, Tafuri A and Jakubowski A 1991 Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid);N. Engl. J. Med. 324 1385–1393

    PubMed  Article  Google Scholar 

  • Warrell R P Jr, He L Z, Richon V, Calleja E and Pandolfi P P 1998 Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase;J. Natl. Cancer Inst. 90 1621–1625

    PubMed  Article  CAS  Google Scholar 

  • Watanabe, Nomura S and Kaneko S 1988 Intracellular factors involved in erythroid differentiation of mouse erythroleukemia (MEL) cells; inThe Status of differentiation therapy of cancer (eds) S Waxman, G B Rossi and F Takaku (New York: Serono Symposia Publications from Raven Press) vol. 45, pp 215–228

    Google Scholar 

  • Wells R A, Catzavelos C and Kamel-Reid S 1997 Rusion of retinoic acid receptor a to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukemia;Nat. Genet. 17 109–113

    PubMed  Article  CAS  Google Scholar 

  • Yeyati P L, Shaknovich R and Boterashvili S 1999 Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A;Oncogene 18 925–934

    PubMed  Article  CAS  Google Scholar 

  • Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R and Naoe T 1996 Accelerated degradation of PML-retinoic acid receptor a (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia;Cancer Res. 56 2945–2948

    Google Scholar 

  • Yu M, Tong J H, Mao M, Kan L X, Liu M M, Sun Y W, Fu G, Jing Y K, Yu L, Lepaslier D, Lanotte M, Wang Z Y, Chen Z, Waxman S, Wang Y X, Tan J Z and Chen S J 1997 Cloning of a gene (RIG-G) associated with retinoic acid induced differentiation of APL cells and representing a new member of a family of the interferon stimulated genes;Proc. Natl. Acad. Sci. USA 94 7406–7411

    PubMed  Article  CAS  Google Scholar 

  • Zhu J, Gianni M, Kopf E, Honore N, Chelbi-Alix M, Koken M, Quignon F, Rochette-Egly C and de The H 1999 Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor a (RARα) and oncogenic RARα fusion proteins;Proc. Natl. Acad. Sci. USA 96 14807–14812

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Zhu Chen.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zhang, JW., Gu, J., Wang, ZY. et al. Mechanisms ofall-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. J Biosci 25, 275–284 (2000). https://doi.org/10.1007/BF02703936

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02703936

Keywords

  • Acute promyelocytic leukemia
  • differentiation
  • retinoic acid